Zobrazeno 1 - 10
of 472
pro vyhledávání: '"Gasiorowski, R."'
Autor:
Thieblemont C; Assistance Publique & Hôpitaux de Paris (APHP), Hôpital Saint-Louis, Hémato-oncologie, Université de Paris, Paris, France. catherine.thieblemont@aphp.fr., Karimi YH; Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI, USA., Ghesquieres H; Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Pierre-Bénite, France., Cheah CY; Sir Charles Gairdner Hospital and the University of Western Australia, Nedlands, Australia., Clausen MR; Vejle Hospital, Vejle, Denmark., Cunningham D; The Royal Marsden NHS Foundation Trust, Sutton, UK., Jurczak W; MSC National Research Institute of Oncology, Kraków, Poland., Do YR; Keimyung University Dongsan Medical Center, Daegu, Republic of Korea., Gasiorowski R; Concord Hospital, University of Sydney, Sydney, Australia., Lewis DJ; University Hospitals Plymouth NHS Trust, Derriford Hospital, Plymouth, UK., Kim TM; Seoul National University Hospital, Seoul, Republic of Korea., van der Poel M; Lunenburg Lymphoma Phase I/II Consortium-HOVON/LLPC, Maastricht, Department of Internal Medicine, Division of Hematology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands., Poon ML; National University Hospital, Singapore, Singapore., Feldman T; John Theurer Cancer Center at Hackensack Meridian Health, Hackensack Meridian Health School of Medicine, Hackensack, NJ, USA., Linton KM; The Christie NHS Foundation Trust, Manchester Cancer Research Centre, and Division of Cancer Sciences, University of Manchester, Manchester, UK., Sureda A; Clinical Hematology Department, Institut Català d'Oncologia - L'Hospitalet, IDIBELL, Universitat de Barcelona, Barcelona, Spain., Hutchings M; Rigshospitalet and University of Copenhagen, Copenhagen, Denmark., Dinh MH; AbbVie, North Chicago, IL, USA., Kilavuz N; Genmab, Plainsboro, NJ, USA., Soong D; Genmab, Plainsboro, NJ, USA., Mark T; Genmab, Copenhagen, Denmark., Sacchi M; Genmab, Plainsboro, NJ, USA., Phillips T; University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA.; City of Hope, Duarte, CA, USA., Lugtenburg PJ; Lunenburg Lymphoma Phase I/II Consortium-HOVON/LLPC, Erasmus MC Cancer Institute, Department of Hematology, University Medical Center, Rotterdam, The Netherlands.
Publikováno v:
Leukemia [Leukemia] 2024 Dec; Vol. 38 (12), pp. 2653-2662. Date of Electronic Publication: 2024 Sep 25.
Autor:
Arzivian A; Gastroenterology Department, Macquarie University Hospital, Sydney, NSW, Australia., Jones B; Gastroenterology Department, Macquarie University Hospital, Sydney, NSW, Australia., Joshua F; Rheumatology Department, Macquarie University Hospital, Sydney, NSW, Australia., Paul M; Douglass Hanly Moir Pathology, Macquarie Park, Sydney, NSW, Australia., Lynch T; Douglass Hanly Moir Pathology, Macquarie Park, Sydney, NSW, Australia., Brown M; Cardiology Department, Macquarie University Hospital, Sydney, NSW, Australia., Gasiorowski R; Haematology Department, Macquarie University Hospital, Sydney, NSW, Australia.
Publikováno v:
Case reports in gastroenterology [Case Rep Gastroenterol] 2024 Apr 20; Vol. 18 (1), pp. 221-230. Date of Electronic Publication: 2024 Apr 20 (Print Publication: 2024).
Autor:
Thieblemont C; Assistance Publique & Hôpitaux de Paris (APHP), Hôpital Saint-Louis, Hémato-oncologie, Université de Paris, Paris, France., Phillips T; University of Michigan Comprehensive Cancer Center, Ann Arbor, MI., Ghesquieres H; Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Pierre-Bénite, France., Cheah CY; Sir Charles Gairdner Hospital, Perth, Australia.; Division of Internal Medicine, Medical School, University of Western Australia, Perth, Australia., Clausen MR; Vejle Hospital, Vejle, Denmark., Cunningham D; The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom., Do YR; Keimyung University Dongsan Medical Center, Daegu, Republic of Korea., Feldman T; Hackensack Meridian Health Hackensack University Medical Center, Hackensack, NJ., Gasiorowski R; Concord Hospital, University of Sydney, Sydney, Australia., Jurczak W; MSC National Research Institute of Oncology, Kraków, Poland., Kim TM; Seoul National University Hospital, Seoul, Republic of Korea., Lewis DJ; University Hospitals Plymouth NHS Trust, Derriford Hospital, Plymouth, United Kingdom., van der Poel M; On behalf of the Lunenburg Lymphoma Phase I/II Consortium-HOVON/LLPC, Maastricht, Department of Internal Medicine, Division of Hematology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands., Poon ML; National University Hospital, Singapore., Cota Stirner M; AbbVie, North Chicago, IL., Kilavuz N; Genmab, Princeton, NJ., Chiu C; Genmab, Princeton, NJ., Chen M; Genmab, Princeton, NJ., Sacchi M; Genmab, Princeton, NJ., Elliott B; Genmab, Princeton, NJ., Ahmadi T; Genmab, Princeton, NJ., Hutchings M; Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Lugtenburg PJ; On behalf of the Lunenburg Lymphoma Phase I/II Consortium-HOVON/LLPC, Erasmus MC Cancer Institute, University Medical Center, Department of Hematology, Rotterdam, the Netherlands.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 Apr 20; Vol. 41 (12), pp. 2238-2247. Date of Electronic Publication: 2022 Dec 22.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Thieblemont, C., Karimi, Y., Jurczak, W., Cheah, C. Y., Clausen, M. R., Cunningham, D., Do, Y. R., Lewis, D. J., Gasiorowski, R., Kim, T. M., van der Poel, M., Poon, M. L., Feldman, T., Linton, K. M., Sureda, A., Hutchings, M., Cottereau, A., Al Tabaa, Y., Stirner, M. Cota, Liu, Y.
Publikováno v:
Hematological Oncology; Jun2023 Supplement 1, Vol. 41, p142-144, 3p
Autor:
Lavie, D., Johnson, N., Borchmann, P., Herrera, A. F., Avigdor, A., Gasiorowski, R., Gregory, G., Keane, C., Vucinic, V., Bazargan, M., Herishanu, Y., Minuk, L., Tzoran, I., Andreadis, C., Armand, P., Kuruvilla, J., Zinzani, P. L., West, R. Marceau, Pillai, P., Marinello, P.
Publikováno v:
Hematological Oncology; Jun2023 Supplement 1, Vol. 41, p364-366, 3p
Autor:
Gasiorowski R; University of Sydney., Trotman J; University of Sydney.
Publikováno v:
Blood [Blood] 2022 Aug 25; Vol. 140 (8), pp. 799-800.
Autor:
Kordyasz, A.J. *, Nossarzewska-Orłowska, E., Piasecki, E., Lipiński, D., Brzozowski, A., Kownacki, J., Kowalczyk, M., Świderski, Ł., Syntfeld, A., Reissig, L., Pietrzak, A., Jakubowski, A., Pozorek, R., Ga̧siorowski, R.
Publikováno v:
In Nuclear Inst. and Methods in Physics Research, A 2004 530(1):87-91
Autor:
Kordyasz, A.J *, Nossarzewska-Orłowska, E, Piasecki, E, Lipiński, D, Brzozowski, A, Kownacki, J, Kowalczyk, M, Świderski, Ł, Syntfeld, A, Reissig, L, Pietrzak, A, Jakubowski, A, Pozorek, R, Ga̧siorowski, R
Publikováno v:
In Nuclear Inst. and Methods in Physics Research, A 2004 528(3):721-730
Integrated clinical and genomic evaluation of guadecitabine (SGI-110) in peripheral T-cell lymphoma.
Autor:
Wong J; Monash Haematology, Monash Health, Clayton, VIC, Australia.; Blood Cancer Therapeutics Laboratory, Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia., Gruber E; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, Australia.; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Maher B; Monash Haematology, Monash Health, Clayton, VIC, Australia.; Blood Cancer Therapeutics Laboratory, Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia., Waltham M; Blood Cancer Therapeutics Laboratory, Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia., Sabouri-Thompson Z; Blood Cancer Therapeutics Laboratory, Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia., Jong I; Monash Health Imaging, Monash Health, Clayton, VIC, Australia.; Department of Imaging, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia., Luong Q; Blood Cancer Therapeutics Laboratory, Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia., Levy S; Monash Health Imaging, Monash Health, Clayton, VIC, Australia.; Department of Imaging, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia., Kumar B; Monash Pathology, Monash Health, Clayton, VIC, Australia., Brasacchio D; Blood Cancer Therapeutics Laboratory, Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia., Jia W; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., So J; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Skinner H; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Lewis A; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Hogg SJ; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, Australia.; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Vervoort S; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, Australia.; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., DiCorleto C; Monash Haematology, Monash Health, Clayton, VIC, Australia., Uhe M; Monash Haematology, Monash Health, Clayton, VIC, Australia., Gamgee J; Monash Haematology, Monash Health, Clayton, VIC, Australia., Opat S; Monash Haematology, Monash Health, Clayton, VIC, Australia.; Blood Cancer Therapeutics Laboratory, Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia., Gregory GP; Monash Haematology, Monash Health, Clayton, VIC, Australia.; Blood Cancer Therapeutics Laboratory, Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia., Polekhina G; Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia., Reynolds J; Biostatistics Consulting Platform, Monash University and Alfred Health, Prahran, VIC, Australia., Hawkes EA; Olivia Newton John Cancer Wellness and Research Centre, at Austin Health, Heidelberg, VIC, Australia.; Transfusion Research Unit, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia., Kailainathan G; Haematology Department, Concord Repatriation General Hospital, Concord, NSW, Australia., Gasiorowski R; Haematology Department, Concord Repatriation General Hospital, Concord, NSW, Australia.; University of Sydney, Sydney, NSW, Australia., Kats LM; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, Australia.; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Shortt J; Monash Haematology, Monash Health, Clayton, VIC, Australia. jake.shortt@monash.edu.; Blood Cancer Therapeutics Laboratory, Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia. jake.shortt@monash.edu.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, Australia. jake.shortt@monash.edu.; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. jake.shortt@monash.edu.
Publikováno v:
Leukemia [Leukemia] 2022 Jun; Vol. 36 (6), pp. 1654-1665. Date of Electronic Publication: 2022 Apr 22.